These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7221214)

  • 1. [Main urinary metabolite of prostaglandin F levels in patients with several pulmonary diseases (author's transl)].
    Takahashi W; Uchiyama K; Murao M; Ohki S; Inagawa T; Hirata F
    Kokyu To Junkan; 1980 Oct; 28(10):1167-73. PubMed ID: 7221214
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of main urinary metabolite of PGFs in chronic lung diseases.
    Murao M; Uchiyama K; Takahashi W; Hirata F; Inagawa T
    Adv Prostaglandin Thromboxane Res; 1980; 7():965-8. PubMed ID: 7369061
    [No Abstract]   [Full Text] [Related]  

  • 3. [The quantities of main urinary metabolite of PGF, plasma PGF and plasma PGE in pulmonary diseases].
    Takahashi W
    Hokkaido Igaku Zasshi; 1982 May; 57(3):303-15. PubMed ID: 7129348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lung disease and PGF2alpha-MUM (main urinary metabolites)].
    Kitamura S
    Nihon Rinsho; 1978 May; Suppl():1892-3. PubMed ID: 691564
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioimmunoassay of the main urinary metabolite of prostaglandin F2 alpha in normal subjects after oral administration of prostaglandins E2 and F2 alpha.
    Kitamura S; Ishihara Y
    Adv Prostaglandin Thromboxane Res; 1980; 6():213-7. PubMed ID: 7386260
    [No Abstract]   [Full Text] [Related]  

  • 6. [Urinary catecholamine excretion in chronic pulmonary disease--with particular reference to its relations to subjective symptoms, blood gases and pulmonary function--(author's transl)].
    Tokoro T
    Kokyu To Junkan; 1977 Mar; 25(3):235-40. PubMed ID: 557825
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioimmunoassay of main urinary metabolite of prostaglandin F2alpha in patients with diffuse interstitial fibrosing pneumonitis (DIFP) and other respiratory diseases.
    Kitamura S; Ishihara Y; Kosaka K
    Tohoku J Exp Med; 1979 Feb; 127(2):177-81. PubMed ID: 760264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of main urinary metabolite of prostaglandin-F2 alpha during pregnancy, labor and the early postpartum period (author's transl)].
    Hisa Y; Tanizawa O; Yamaji K; Kurachi K
    Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1313-21. PubMed ID: 510631
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental and clinical studies of a prostaglandin F2-alpha main urinary metabolite (MUM) radioimmunoassay kit].
    Sato K; Fukagawa M
    Horumon To Rinsho; 1978 Feb; 26(2):197-204. PubMed ID: 630736
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measurement of prostaglandin F in the plasma of healthy men (author's transl)].
    Castañeda-Peña G; Zamora-López G; Cortés-Gallegos V
    Rev Invest Clin; 1978; 30(3):283-9. PubMed ID: 694268
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with the measurement of "closing volume" in healthy subjects and in patients with pulmonary disease (author's transl)].
    Stangl B; Kandare F; Bizjak M; Sorli J; Miklavzic U; Grobovsek S
    Plucne Bolesti Tuberk; 1976; 28(1-2):52-7. PubMed ID: 1013232
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of the effects of alveolar pressure on pulmonary hemodynamics with special reference to pulmonary arterial diastolic pressure in pulmonary patients (author's transl)].
    Sada K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Apr; 18(4):211-22. PubMed ID: 7392325
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioimmunoassay of main urinary metabolite of prostaglandin F2alpha in normal subjects.
    Kitamura S; Ishihara Y; Kosaka K
    Prostaglandins; 1977 Nov; 14(5):961-5. PubMed ID: 594394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The levels of main urinary metabolite of prostaglandin F1alpha and F2alpha in human subjects measured by radioimmunoassay.
    Ohki S; Nishigaki Y; Imaki K; Kurono M; Hirata F
    Prostaglandins; 1976 Aug; 12(2):181-6. PubMed ID: 959583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of main urinary metabolite of prostaglandin F2alpha.
    Oki S; Imaki K; Hirata F; Hanyu T; Nakazawa N
    Prostaglandins; 1975 Oct; 10(4):549-55. PubMed ID: 812153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased urinary F(2)-isoprostanes levels in the patients with Alzheimer's disease.
    Kim KM; Jung BH; Paeng KJ; Kim I; Chung BC
    Brain Res Bull; 2004 Jul; 64(1):47-51. PubMed ID: 15275956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A fortultousness association: Bartter's syndrome and chondrocalcinosis (author's transl)].
    Goulon M; Raphael JC; De Rohan P
    Nouv Presse Med; 1980 Apr; 9(18):1291-5. PubMed ID: 7375363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic and methodologic variables affecting urinary prostaglandin measurement.
    Ciabattoni G; Pugliese F; Pinca E; Cinotti GA; De Salvo A; Satta MA; Patrono C
    Adv Prostaglandin Thromboxane Res; 1980; 6():207-12. PubMed ID: 7386259
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prostaglandin levels in amniotic fluid during normal advanced pregnancy (author's transl)].
    Nieder J; Augustin W
    Zentralbl Gynakol; 1981; 103(4):204-13. PubMed ID: 7234221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of urinary prostaglandin excretion by stop-flow analysis in dogs.
    Cinotti GA; Stirati G; Pecci G; Pierucci A; Pugliese F; Simonetti BM; Ciabattoni G; Benedetti Valentini F; Patrono C
    Minerva Nefrol; 1981; 28(3):203-8. PubMed ID: 7329596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.